Denver Health and Hospital Authority
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Denver Health and Hospital Authority sits in the top decile of US sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count).
Denver Health and Hospital Authority: 73 sponsored US clinical trials, 4 recruiting.
Denver Health and Hospital Authority sponsors 73 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 59 completed. 10 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, Binge Eating/Purging Type, with 2 trials.
Top-decile sponsor footprint
Denver Health and Hospital Authority ranks in the top decile of sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
59 of 68 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
73 total, page 2 of 2
IV Iron for the Anemia of Traumatic Critical Illness
NCT01180894
Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma
NCT01536496
Chronic Care Management/Patient Relationship Management Proof of Concept
NCT01182480
Motivational Interviews for Depression in Primary Care
NCT01114334
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
NCT01050153
An Intervention to Improve Communication Between Physicians and Minority Patients With Hypertension
NCT01037920
Acetaminophen-Protein Adduct Resolution
NCT01021410
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
NCT00935766
Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill Patients
NCT00938002
Aminotransferase Trends During Prolonged Acetaminophen Dosing
NCT00743093
Bacterial Contamination of Workwear
NCT01192841
Accuracy of the Transpatellar Tendon Approach to Knee Arthrocentesis
NCT00888368
Automated Diabetes Registry Tools to Enhance Patient Self-Management and Provider Performance Feedback
NCT00827710
Splinting Versus Not Splinting of the Distal Lower Extremity After Intramedullary Nailing for Tibial Fractures
NCT00888550
Evaluation of a Navigator-Nurse Care Team on the Management of High Blood Pressure and Cardiovascular Disease Risk
NCT00523536
Evaluation of Opt-Out Rapid HIV Testing in the Emergency Department
NCT00742898
Denver Health Cardiovascular Disease (CVD) Prevention Program
NCT00829491
Beta Blockade in Critical Injury
NCT00356187
Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder
NCT00399763
Nurse Telephone Management of Cholesterol in Diabetes
NCT00950963
Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing
NCT00427206
Effects of Carvedilol on Health Outcomes in Heart Failure
NCT00381030
Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics
NCT00402571
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 5 |
| Phase 3 | 2 |
| Phase 4 | 8 |
What is open in the Denver Health and Hospital Authority pipeline
4 recruiting of 73 indexed (5% open); 59 completed (81%).
Phase mix: 10 late (III/IV) vs 8 early (I/II) (balanced across stages).
Top condition: Anorexia Nervosa, Binge Eating/Purging Type (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Denver Health and Hospital Authority: open-pipeline peers nationwide
Peers matched on 73 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
Denver Health and Hospital Authority sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 73 trials (± recruiting share)
- Hugo W. Moser Research Institute at Kennedy Krieger · 73 trials · 23% recruiting
- Joslin Diabetes Center · 73 trials · 10% recruiting
- Massachusetts Eye and Ear Infirmary · 73 trials · 27% recruiting
- Tulane University · 73 trials · 30% recruiting
Sponsors near 5% open enrollment (± trial volume)
- Harvard University · 5% recruiting · 37 trials
- Boston College · 6% recruiting · 18 trials
- CytoDyn · 6% recruiting · 18 trials
- Dendreon · 6% recruiting · 18 trials
Related
What to do with this Denver Health and Hospital Authority page
73 registered trials is a research-attention snapshot, not an endorsement of Denver Health and Hospital Authority or any single study.
- 4 of Denver Health and Hospital Authority's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa, Binge Eating/Purging Type is the condition Denver Health and Hospital Authority studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa, Binge Eating/Purging Type trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Denver Health and Hospital Authority pipeline card: 73 registered trials from official public datasets.Report a data error.